Key result
Deferred coronary artery stenting is a promising two-stage revascularization technique for preventing no-reflow in patients with acute ST-segment elevation myocardial infarction and severe thrombosis.
Why the study?
Despite timely revascularization, some patients experience myocardial hypoperfusion known as the no-reflow phenomenon, which carries an unfavorable prognosis.
Does deferred stenting prevent no-reflow in patients with acute ST-segment elevation myocardial infarction?
Systematic Review
Does deferred stenting prevent no-reflow in patients with acute ST-segment elevation myocardial infarction?
Deferred stenting may be a promising two-stage revascularization strategy to prevent the no-reflow phenomenon in STEMI patients with severe thrombosis.
Supports deferred stenting to prevent no-reflow in high-thrombus STEMI; extends prior data through systematic synthesis.
It is known that even in spite of timely revascularization of the infarct-related artery, the myocardium in some patients remains hypoperfused. This condition is known as the no-reflow phenomenon, which is associated with an unfavorable prognosis. The systematic review is devoted to the effectiveness of deferred stenting in noreflow prevention. In patients with severe thrombosis, the two-stage revascularization technique is very promising. It is a primary intervention in the form of aspiration thrombectomy and/or balloon angioplasty followed by stenting after a certain period of time. This interval represents a certain therapeutic space, which allows various drugs to act resulting in reduction of blood clot size and risk of procedure-related distal embolization.
No takes yet. Share an insight, caveat, or question.
Аzarov et al. (2021) conducted a systematic review in Acute ST-segment elevation myocardial infarction. Deferred coronary artery stenting was evaluated on Prevention of no-reflow. Deferred coronary artery stenting is a promising two-stage revascularization technique for preventing no-reflow in patients with acute ST-segment elevation myocardial infarction and severe thrombosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: